QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Absorption, distribution, metabolism, and excretion of [C-14]NBP (3-n-butylphthalide) in rats 期刊论文 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2021, 卷号: 1181, 页码: 9 作者:  Tian, Junjun;  Lei, Peng;  He, Yifei;  Zhang, Ning;  Ge, Xinyu 收藏  |  浏览/下载：49/0  |  提交时间：2021/11/04 3-n-butylphthalide (NBP)  [C-14]NBP  Pharmacokinetics  Tissue distribution  Metabolism  Mass balance   Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers 期刊论文 CLINICAL THERAPEUTICS, 2021, 卷号: 43, 期号: 9, 页码: E264-E273 作者:  Chen, Zhen-dong;  Chen, Qian;  Zhu, Yun-ting;  Zhang, Yi-fan;  Zhan, Yan 收藏  |  浏览/下载：38/0  |  提交时间：2022/01/04 henagliflozin  food effects  mass balance  pharmacokinetics  SGLT-2 inhibitor   Itraconazole and rifampicin, as CYP3A modulators but not P-gp modulators, affect the pharmacokinetics of almonertinib and active metabolite HAS-719 in healthy volunteers 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 9 作者:  Liu, Lu;  Li, Wei;  Yang, Le;  Guo, Zi-tao;  Xue, Hao 收藏  |  浏览/下载：78/0  |  提交时间：2021/08/17 almonertinib  itraconazole  rifampicin  drug metabolism  drug interaction  CYP3A  P-gp  pharmacokinetics   Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity 期刊论文 DRUG METABOLISM AND DISPOSITION, 2021, 卷号: 49, 期号: 4, 页码: 305-313 作者:  Qiao, Shida;  Feng, Sisi;  Wu, Zhitao;  He, Ting;  Ma, Chen 收藏  |  浏览/下载：27/0  |  提交时间：2021/05/24 Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration 期刊论文 CLINICAL THERAPEUTICS, 2021, 卷号: 43, 期号: 2, 页码: 396-409 作者:  Zhang, Yi-fan;  Liu, Yan-mei;  Yu, Chen;  Wang, Ya-ting;  Zhan, Yan 收藏  |  浏览/下载：69/0  |  提交时间：2021/05/24 diabetes  henagliflozin  pharmacodynamics  pharmacokinetics  SGLT-2 inhibitors   UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples 期刊论文 CURRENT DRUG METABOLISM, 2021, 卷号: 22, 期号: 6, 页码: 491-499 作者:  Chen, Wei-Ying;  Liang, Guang-Yan;  Zheng, Zuo-Liang;  Wu, Yun-Shan;  Xu, Fang-Fang 收藏  |  浏览/下载：42/0  |  提交时间：2021/11/04 Protosappanin B  Metabolic pathways  UPLC-TOF-MS  MS  Plasma  Bile  Feces  Urine  Intestinal bacteria sample